Achieving Molecular Remission before Allogeneic Stem Cell Transplantation in Adult Patients with Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia: Impact on Relapse and Long-Term Outcome-Reference-Cited by-同舟云学术

Achieving Molecular Remission before Allogeneic Stem Cell Transplantation in Adult Patients with Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia: Impact on Relapse and Long-Term Outcome

Published:2016-11 Issue:11 Volume:22 Page:1983-1987
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Lussana Federico,Intermesoli Tamara^ORCID,Gianni Francesca,Boschini Cristina,Masciulli Arianna,Spinelli Orietta,Oldani Elena,Tosi Manuela,Grassi Anna,Parolini Margherita,Audisio Ernesta,Cattaneo Chiara,Raimondi Roberto,Angelucci Emanuele^ORCID,Cavattoni Irene Maria,Scattolin Anna Maria,Cortelezzi Agostino,Mannelli Francesco,Ciceri Fabio,Mattei Daniele,Borlenghi Erika,Terruzzi Elisabetta,Romani Claudio,Bassan Renato,Rambaldi Alessandro

Funder

Associazione Italiana Lotta alla Leucemia (AIL) sezione di Bergamo

Associazione Italiana per la Ricerca sul Cancro (AIRC)

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference30 articles.

1. Modern therapy of acute lymphoblastic leukemia;Bassan;J Clin Oncol,2011

2. Prospective outcome data on 267 unselected adult patients with Philadelphia chromosome–positive acute lymphoblastic leukemia confirms superiority of allogeneic transplantation over chemotherapy in the pre-imatinib era: results from the International ALL Trial MRC UKALLXII/ECOG2993

3. Treatment of Philadelphia chromosome-positive acute lymphocytic leukemia with hyper-CVAD and imatinib mesylate;Thomas;Blood,2004

4. Imatinib combined with induction or consolidation chemotherapy in patients with de novo Philadelphia chromosome-positive acute lymphoblastic leukemia: results of the GRAAPH-2003 study;de Labarthe;Blood,2007

5. Chemotherapy-phased imatinib pulses improve long-term outcome of adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: Northern Italy Leukemia Group protocol 09/00;Bassan;J Clin Oncol,2010

Cited by 79 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MRD in Philadelphia Chromosome-Positive ALL: Methodologies and Clinical Implications;Current Hematologic Malignancy Reports;2024-06-18

2. Donor matters: Donor selection impact on hematopoietic stem cell transplantation outcomes in Hispanic patients with B-cell acute lymphocytic leukemia: Insights from a myeloablative HSCT study;Leukemia Research;2024-06

3. Effect of sustained measurable residue disease negativity and post‐remission treatment selection on the prognosis of acute lymphoblastic leukemia in adults;Cancer Medicine;2024-05

4. Impact of minimal residual disease response and of status of disease on survival after blinatumomab in B-cell acute lymphoblastic leukemia: results from a real-life study;Annals of Hematology;2024-04-13

5. Impact of minimal residual disease response and of status of disease on survival after Blinatumomab in B-Cell Acute Lymphoblastic Leukemia: results from a Real-Life Study. Running title: MRD-response and Disease Status correlate with survival after Blinatumomab in ALL-B patients;2024-03-05